{"retracted":false,"update":{"timestamp":1410307200000,"doi":"10.1007/s40261-014-0232-z","type":"correction"},"doi":"10.1007/s40261-014-0224-z","journal":"Clinical Drug Investigation","publisher":"Springer Nature","title":"Erratum to: Cost Effectiveness of Apixaban Versus Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in Belgium"}
